|
MODERNA- NASDAQ:MRNA
|
|
Resverlogix Corp.
|
Apr 15, 2020 09:39AM
|
|
More Exempt Distribution Investments
|
3
|
Zenith Epigenetics
|
Jan 05, 2024 02:49PM
|
|
More insider buying
|
3
|
Resverlogix Corp.
|
Jun 26, 2022 10:44AM
|
|
National Kidney Foundation -Abstract: BOM
|
1
|
Resverlogix Corp.
|
Mar 30, 2020 02:37PM
|
|
New Video -@ the BIO
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 08:45AM
|
|
New-Report of exempt distribution
|
4
|
Resverlogix Corp.
|
Jan 05, 2021 04:22PM
|
|
New-Report of exempt distribution
|
5
|
Resverlogix Corp.
|
Nov 13, 2020 12:56PM
|
|
News Alert
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 07, 2020 09:16AM
|
|
News Release - May 30, 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 31, 2019 09:32AM
|
|
Nine Months, 2021- Financials and MD&A on SEDAR
|
1
|
Resverlogix Corp.
|
Nov 13, 2021 06:38AM
|
|
Not out of the woods yet with COVID-19
|
6
|
Resverlogix Corp.
|
Feb 18, 2022 07:48AM
|
|
Notice of meeting
|
4
|
BIOASIS TECHNOLOGIES INC
|
Nov 01, 2018 04:07PM
|
|
Novartis & Pfizer withdraw drug application in Europe
|
4
|
Resverlogix Corp.
|
Dec 23, 2018 09:20AM
|
|
Number of Directors
|
2
|
Resverlogix Corp.
|
Sep 29, 2019 12:48PM
|
|
Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardio Benefits at Euro Society of Cardiology Congress 2024
|
4
|
Resverlogix Corp.
|
Sep 03, 2024 10:33AM
|
|
October 24, 2023 How SARS-CoV-2 contributes to heart attacks and strokes
|
3
|
Resverlogix Corp.
|
Oct 29, 2023 08:36AM
|
|
Oil Stocks
|
1
|
Resverlogix Corp.
|
Apr 10, 2020 04:36AM
|
|
On Yahoo
|
6
|
Resverlogix Corp.
|
Oct 31, 2019 01:33PM
|
|
One More Promissory Note-Aug 9/24
|
2
|
Zenith Epigenetics
|
Aug 14, 2024 07:22AM
|
|
Posters sued successfully
|
2
|
Resverlogix Corp.
|
Jan 16, 2020 01:19PM
|
